Nuclear Medicine
FLUORIDE
Name:
Oseopet Radiofarma
Active Principle:
Sodium Fluoride (18F)
Therapeutic Action:
It is indicated for the evaluation of areas of altered osteogenic activity in recurrent or metastatic primary disease of various tumors.
Nuclear Medicine
FLUORIDE
Name:
Oseopet Radiofarma
Active Principle:
Sodium Fluoride (18F)
Therapeutic Action:
It is indicated for the evaluation of areas of altered osteogenic activity in recurrent or metastatic primary disease of various tumors.
RELATED PRODUCTS
-
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test. -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...

